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Abstract
Background: Non-communicable diseases (NCDs) place enormous burdens on individuals and health systems.
While there has been significant global progress to guide the development of national NCD monitoring programs,
many countries still struggle to adequately establish critical information systems to prioritise NCD control approaches.
Discussion: In this paper, we use the recent experience of the Pacific as a case study to highlight four key lessons
about prioritising strategies for health information system development for monitoring NCDs: first, NCD interventions
must be chosen strategically, taking into account local disease burden and capacities; second, NCD monitoring efforts
must align with those interventions so as to be capable of evaluating progress; third, in order to ensure efficiency and
sustainability, NCD monitoring strategies must be integrated into existing health information systems; finally, countries
should monitor the implementation of key policies to control food and tobacco industries.
Summary: Prioritising NCD interventions to suit local needs is critical and should be accompanied by careful
consideration of the most appropriate and feasible monitoring strategies to track and evaluate progress.
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Background
A United Nations High-Level Meeting in 2011 drew at-
tention to the urgent need to control the global non-
communicable disease (NCD) epidemic [1]. However,
progress has been very slow [2]. The 2014 global review,
which took stock of advances since 2011, recognised the
critical importance of effective monitoring and surveillance
systems in combating NCDs, but said little about the enor-
mous challenges faced by member states in collecting the
relevant data to support NCD control efforts. There has
been a systematic failure to invest, lead, and catalyse essen-
tial health information system developments to reliably
monitor progress with NCD programs and policies. The
implication is that countries will not be able to effectively
inform and evaluate their intervention strategies for some
of the most pressing global public health threats, including
tobacco, obesity, sub-optimal blood pressure, and other
key determinants of increased cardiovascular disease risk.
Well-functioning health information systems, civil registra-
tion and vital statistics in particular, are essential for more
effectively tackling health challenges, ensuring accountabil-
ity and providing the essential health intelligence to inform
strategies to improve population health [3, 4].
Although age-standardised NCD death rates are de-
creasing worldwide, deaths due to NCDs make up a
growing proportion of all deaths globally [5], including
in the Pacific [6]. The disability caused by NCDs places
enormous burdens on individuals and health systems,
slowing economic development and threatening liveli-
hoods [7, 8]. Decades of research have identified a num-
ber of NCD ‘best-buy’ interventions [9]; nevertheless,
limited national resources and capacity are likely to
mean that countries will need to prioritise their strategic
options [2], including efforts to monitor NCDs and to
promote accountability.
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There has been important progress in guiding national
strategies to monitor NCDs. In 2013, the World Health
Assembly adopted the ‘Comprehensive Global Monitor-
ing Framework, indicators and targets for the prevention
and control of NCDs’ (GMF), including nine targets (an
NCD premature mortality reduction target, six risk factor
targets, and two health system targets) to be achieved by
2025 with 2010 as the baseline. Twenty five indicators to
track progress towards these targets are listed in Table 1.
Despite this excellent conceptual basis for comprehensive
NCD control, countries may struggle to establish and/or
maintain adequate monitoring systems to reliably inform
what progress, or not, they are making in controlling
NCDs.
Moreover, data requirements for more effective NCD
control are only one component of a broader demand
on countries for reliable burden of disease data. The re-
cent Ebola outbreak highlighted the tragic vulnerability
of populations in the absence of strong health surveillance
and health systems. At the same time, the evaluation of
national progress towards Millennium Development Goal
targets has been hampered by the lack of reliable, timely,
and comparable data in most low- and middle-income
countries (LMICs) [10]. Negotiations surrounding the
new sustainable development agenda have demonstrated
that the debate has shifted from one about ‘what works’
to issues of accountability. The new development goals
should provide the necessary incentive to strengthen
surveillance systems in order to ensure accountability
frameworks can be upheld. A recent high-level summit
on Measurement and Accountability for Results in Health
[11] suggests that the central role of data systems in devel-
opment is increasingly recognised. In light of these ad-
vances, the state of national health information systems
and the actions necessary to improve them will hopefully
gain greater prominence.
Epidemiological transition in the Pacific
In this paper, we focus on the pressing need to adequately
incorporate NCDs into this evolving health measurement
and accountability dialogue and suggest a framework for
prioritising monitoring efforts, particularly in resource-
poor countries. Over the past two decades, Pacific Island
Countries and Territories (PICTs) have seen a rapid in-
crease in NCDs and now suffer from some of the highest
burdens due to NCDs in the world [12]. The Global Bur-
den of Disease has estimated that NCDs amongst those
PICTs (for which data is available) made up 33.6 % of the
total disease burden in 1990, rising to 47.7 % in 2010 [13].
Additionally, obesity levels are some of the highest in the
world; prevalence of obesity amongst females is over 75 %
in four Pacific countries and between 12.4 % and 53.4 % of
people aged between 25 and 64 are affected by diabetes
[14]. Furthermore, the prevalence of NCD risk factors,
such as insufficient physical activity, tobacco, and heavy
alcohol consumption, are exceptionally high in a number
of PICT populations, presenting discouraging signs of fu-
ture burdens to come [14]. PICTs, therefore, need to take
urgent action on NCDs. Similar to many other LMICs,
PICTs struggle to address the NCD burdens and are se-
verely hampered by weak health information systems and
a lack of reliable timely data (Table 2). Despite these chal-
lenges and setbacks, PICTs have developed some innova-
tive strategies and collaborations to tackle NCDs. We
use the experiences of the PICTs as a case study of how
to strategically and feasibly enhance monitoring sys-
tems for NCD control through considered choices
about what data to collect and how to ensure their
quality and relevance. This need is especially urgent in
the Pacific given the extraordinary levels of premature
adult mortality [15], but the approach we propose could
equally inform best practice elsewhere.
The Pacific is in the midst of a NCD crisis [16], while
continuing to deal with residual maternal and child health
issues and disease outbreaks. When available, data on
NCDs and causes of death in the Pacific are generally out-
dated or of poor quality (Table 2). Estimates of disease
burden in the region, like those that are reported by the
Global Burden of Disease, are highly uncertain and insuffi-
ciently reliable to monitor changes [17]. PICTs have strug-
gled to develop and maintain health information systems
to collect and analyse data and to report on the health of
their populations. This is further exacerbated by parallel
systems of disease monitoring which, while perhaps meet-
ing development partner requirements, have resulted in
duplication of effort and potentially weakened more
comprehensive health information system development
in countries. Despite recent efforts to rectify these issues,
exemplified by the migration of data collection tools for
HIV, tuberculosis, and NCD programs in the Solomon
Islands into the national health information system
[18], there has been little appreciation of the crucial
role that reliable and timely health information plays in
national disease control strategies. There is a real dan-
ger that the challenges posed by the lack of capacity
currently accessible within these systems will perpetu-
ate the inertia that plagues NCD control efforts in the
region.
Discussion
Based upon the experience of the Pacific thus far in moni-
toring and controlling NCDs, we share four key lessons
that we believe are broadly relevant for health information
systems development so that countries are better prepared
to control their NCD epidemics, accelerate health system
responses, and report on progress between now and 2025,
as called for in the WHO GMF.
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Table 1 Global monitoring framework targets and indicators
Target Indicator
1. (a) Reduce premature mortality from NCDs by 25 % 1. Unconditional probability of dying between ages 30 and 70 years
from cardiovascular disease (CVD), cancer, diabetes, or chronic
respiratory diseases
(b) Cancer morbidity 2. Cancer incidence by type of cancer per 100,000 population
2. At least 10 % relative reduction in the harmful use of alcohol, as
appropriate within the national context
3. Total (recorded and unrecorded) alcohol per capita (15+ years old)
consumption within a calendar year in litres of pure alcohol, as
appropriate within the national context
4. Age-standardised prevalence of heavy episodic drinking among
(adolescents and adults) as appropriate within the national context
5. Alcohol-related morbidity and mortality among adolescents and adults,
as appropriate within the national context
3. 10 % relative reduction in prevalence of insufficient physical activity 6. Age-standardised prevalence of insufficiently active adults aged
18+ years (defined as less than 150 minutes of moderate intensity
activity per week or equivalent)
7. Prevalence of insufficiently physically active adolescents defined as
less than 60 minutes of moderate to vigorous intensity activity daily
4. 30 % reduction in mean population intake of salt/sodium 8. Age-standardised mean population intake of salt (sodium chloride)
per day in grams in adults aged 18+ years
5. 30 % reduction in prevalence of current tobacco smoking 9. Age-standardised prevalence of current tobacco smoking among
persons aged 18+ years
10. Prevalence of current tobacco use among adolescents
6. Halt the rise in diabetes and obesity 11. Age-standardised prevalence of raised blood glucose/diabetes
among adults aged 18+ years (defined as fasting plasma glucose
value ≥7.0 mmol/L (126 mg/dL) or on medication for raised blood
glucose)
12. Age-standardised prevalence of overweight and obesity in adults aged
18+ years (defined as body mass index (BMI) ≥25 kg/m for overweight
or ≥30 kg/m for obesity)
13. Prevalence of overweight and obesity in adolescents (defined
according to the WHO Growth Reference: overweight – one standard
deviation BMI for age and sex, and obese – two standard deviations
BMI for age and sex)
7. (a) 25 % relative reduction in the prevalence of raised blood pressure
or contain the prevalence of raised blood pressure according to
national circumstances
14. Age-standardised prevalence of raised blood pressure among adults
aged 18+ years (defined as systolic blood pressure ≥140 mmHg and/or
diastolic blood pressure ≥90 mmHg) and mean systolic blood pressure
(b) Cholesterol 15. Age-standardised prevalence of raised total cholesterol among
adults aged 18+ years (defined as total cholesterol ≥5.0 mmol/L
or 190 mg/dL
(c) Fat intake 16. Age-standardised mean proportion of total energy intake from
saturated fatty acids and polyunsaturated fatty acids in adults
aged 18+ years
(d) Fruit and vegetable intake 17. Age-standardised prevalence of adult (aged 18+ years) population
consuming less than five total servings (400 g) of fruit and vegetables
per day
8. At least 50 % of eligible people receive drug therapy and counselling
(including glycaemic control) to prevent heart attacks and strokes
18. Proportion of eligible persons (defined as aged 40 years and over
with a 10-year cardiovascular risk greater than or equal to 30 %
including those with existing CVD) receiving drug therapy and
counselling to prevent heart attacks and strokes
9. (a) An 80 % availability of the affordable basic technologies and
essential medicines, including generics, required to treat major
non-communicable diseases in both public and private facilities
19. Availability and affordability of quality, safe, and efficacious essential
non-communicable disease medicines, including generics, and basic
technologies in both public and private facilities
(b) Palliative care 20. Access to palliative care assessed by morphine-equivalent consumption
of strong opioid analgesics (excluding methadone) per death from
cancer
(c) Cervical cancer 21. Proportion of women between the ages of 30 and 49 screened for
cervical cancer at least once, or more often, and for lower and higher
age groups according to programs and policies
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Lesson One: NCD intervention priorities need to be
strategically chosen
Achieving all the globally agreed voluntary targets will
be impossible for many countries, and it is important
that they do not set themselves up for failure. As a key
step towards reducing the major NCD burdens in their
populations, Pacific Ministers of Health and Finance
jointly agreed on a Roadmap for NCDs that set four
intervention priorities: tobacco control, policies to reduce
the consumption of unhealthy foods and drinks, scaling
up NCD interventions in primary healthcare settings, and
strengthening the evidence base to assess NCD program
investments [6]. As Pacific countries progressively roll out
the interventions required and the systems to measure
their success, they also have a menu of 30 other areas they
might address, according to their local circumstances and
needs (see NCD Roadmap [19]). Other countries should
likewise consider the ‘best-buys’ in relation to local NCD
burdens and context to prioritise actions for controlling
and preventing NCDs.
Lesson Two: NCD monitoring strategies must be aligned
with prioritised interventions
Intervention priorities should dictate the monitoring pri-
orities. Many countries are not able to collect all the data
necessary to fulfil the requirements of the NCD frame-
work. Good quality data on a small number of key indi-
cators are likely to be more useful for policy than large
amounts of (often unreliable) data that distract from
the critical information needs to address stated priorities.
To ensure that a country’s health information system is
capable of effectively tracking epidemiological changes, a
minimum dataset should be prioritised and collected. In
the case of NCDs, this consists of reliable and timely vital
registration data to allow continuous monitoring of cause-
specific mortality, cross-sectional surveys of population
exposure to major risk factors for the leading causes of
NCDs – ideally three before 2025 – and periodic docu-
mentation of the effective coverage of key NCD inter-
ventions [20]. Two data sources are essential if countries
are to be able to report progress on NCDs in 2025 –
Table 2 Data sources and availability of relevant data (key population health surveys) from Pacific Island Countries and Territories
(2002–2015)a








Availability of mortality estimates for
2012 (Global Status of NCDs 2014 [37])
Cook Islands 2004 and 2014 – 2010 2010 –
Fiji 2002 and 2011 – 2010 2010 yes
Kiribati 2004–06 (and 2015 near
completion)
2009 2011 2010 –
Nauru 2004 2007 2011 2010 –
Niue 2011 2010 2010 –
Samoa 2004 and 2013 2009 2011 2010 –
Solomon Islands 2006 and 2015 2007 2011 2010 yes
Papua New Guinea 2007–08 1996 and 2006 2007 2010 yes
Tokelau 2005 and 2015 – – –
Tonga 2004 and 2012 2012 2010 2010 –
Tuvalu 2007 2007 2013 2010 –
Vanuatu 2011 2013 2011 2010 –
GSHS, Global School-based Student Health Survey; NCD(s), Non-communicable disease(s); STEPS, WHO STEPwise Surveillance of NCD risk factors
aFor the purpose of this paper United States Affiliated Pacific Island countries were not considered
Table 1 Global monitoring framework targets and indicators (Continued)
(d) Trans-fat elimination 22. Adoption of national policies that virtually eliminate partially
hydrogenated vegetable oils in the food supply and replace with
polyunsaturated fatty acids
(e) Marketing foods to children 23. Policies to reduce the impact on children of marketing of foods high
in saturated fats, trans-fatty acids, free sugars, or salt
(f) Vaccination against cancer-causing infections 24. Vaccination coverage against hepatitis B virus monitored by number
of third doses of Hep-B vaccine (HepB3) administered to infants
25. Availability, as appropriate, if cost-effective and affordable, of vaccines
against human papillomavirus, according to national programmes and
policies
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civil registration and vital statistics systems that reliably
capture all deaths and include established procedures
to document causes of death, including medical certifi-
cation or, where certification is not available, automated
verbal autopsy methods [21]; and the WHO STEPwise
Surveillance of NCD risk factors (STEPS) – or equivalent
– surveys on risk factor levels and patterns in the popula-
tion. Based upon priority interventions and the feasibility
of collecting relevant indicators in PICTs, Fig. 1 presents a
list of prioritised data sources and indicators (further de-
tails on how this prioritisation was conducted can be
found in a the Health Information Systems Knowledge
Hub Working Paper 33 [22]). Strengthening civil registra-
tion and vital statistics systems for registering deaths and
correctly certifying cause of death is the only strategy that
can provide reliable information on changes in NCD mor-
tality patterns [4]. This will require intensive training for
physicians in correct procedures for death certification
and the wider use of automated verbal autopsies to ascer-
tain cause of death in deaths that occur outside hospital
settings. Through the efforts of the Brisbane Accord
Group and the Pacific Vital Statistics Action Plan ,
there is growing recognition of the importance of vital
statistics among PICTs [23], with small but notable im-
provements already apparent in some national vital regis-
tration systems [24]; for example, Fiji has developed and
implemented a comprehensive training program to im-
prove medical certification of death, including routine
data quality audits, and Niue has produced its first vital
statistics report in 20 years.
If STEPS surveys are undertaken, with the addition of
a module on salt and a few additional questions related
to treatment, countries will be able to report on five of
the risk factor targets, including self-reported smoking,
harmful use of alcohol, salt consumption, raised blood
pressure, and physical inactivity, as well as one of the
agreed health system targets, namely treatment with
combination drugs for those at highest absolute risk of
heart attack and stroke. Ideally, all PICTs would have con-
ducted at least two (preferably three, including the base-
line survey) STEPS surveys before reporting on progress
in 2025 [5]. As STEPS was adopted by Pacific countries
relatively early, almost all countries have already estab-
lished baseline measures of risk factor prevalence; four
countries have completed a second round. Commitment
to repeating cross sectional surveys using the same
methodology is key. Greater use of electronic data col-
lection and data analyses packages since 2009 has over-
come earlier challenges that impeded rapid data analyses
and reporting. Selectively including the objectively
measured Step 3 (physical measures and blood collection)
will reduce both cost and complexity. A data analysis and
reporting team is now coordinated by WHO; together
with technical input from the Monitoring Alliance for
NCD Action (MANA), these developments could pro-
vide a platform to assist countries to improve their data
Fig. 1 Priority data sources and indicators necessary for monitoring NCDs [Source: Health Information Systems Knowledge Hub Working Paper 33 (22)]
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systems to inform policy action on NCDs, and support
tracking progress and reporting against the priority tar-
gets set by each country. The proposed NCD Countdown
2025 template [25] and the Pacific MANA dashboard [26]
currently under development could be used to summarise
progress with the overall mortality target and levels of risk
factor prevalence. Other countries and regions where the
capacity of the existing health information systems is
limited could consider similar strategies to prioritising
monitoring efforts.
Lesson Three: NCD monitoring strategies should be
integrated into existing health information systems and
coordinated with existing data strengthening efforts,
such as for civil registration and vital statistics under the
Brisbane Accord Group
Monitoring and surveillance are resource-intensive ac-
tivities. Leaders in the Pacific have expressed concerns
about the large number of goals, targets, and indicators
emerging from discussions on the sustainable develop-
ment goals [27]; though the targets are set 5 years beyond
the 25 by 25 goals, proposals for sustainable development
goal indicators thus far are aligned with GMF indicators.
Ensuring that these targets and indicators are integrated
into existing national systems can help relieve some of the
burden associated with monitoring and surveillance. The
civil registration and vital statistics system is the backbone
of a national health information system. It must be fit for
purpose and its sustainability must be ensured. In the Pa-
cific, the Brisbane Accord Group has provided a valuable
resource to the region offering a collaborative platform for
coordinating the work of partner agencies and providing
strategic and technical support to improve vital statistics,
including data routinely collected from health facilities.
The Brisbane Accord Group has helped develop and sup-
port country-led Civil Registration and Vital Statistics
Committees, which have members from health, statistics,
and registration – ensuring links between all systems and
departments (including Information Technology). An
example of action to strengthening data collection at
the health facility level is provided by ‘PEN (Package of
Essential NCD Interventions) Fa’a Samoa’; an award-
winning community-based programme aimed at early
detection of NCDs in select villages in Samoa. As part
of the initiative, community registration forms collect-
ing data on NCD risk factors are managed by local Vil-
lage Women’s Committees and the programme works
with local hospital hospitals to improve links between out-
reach/primary services and to strengthening medical
records.
Many challenges still remain in PICTs, but steady pro-
gress is evident. Recent initiatives intended to intensify
technical assistance to countries to strengthen civil
registration and vital statistics systems ought to help ac-
celerate this trend [28].
Lesson Four: Develop strategies to monitor the
implementation of selected policies to regulate the food
and tobacco industries
Access to unhealthy foods and products and the trade
agreements that facilitate their consumption and afford-
ability are increasingly recognised as important drivers
of the NCD epidemic [29, 30], acting in a similar fashion
to the promotion of tobacco use. PICTs have been par-
ticularly active in adopting tobacco regulation and con-
trol efforts. Nine Pacific countries have taken action to
implement comprehensive tobacco control through in-
creasing the tobacco tax, an extremely effective tobacco
control measure [31], within the last three years. Minis-
ters of Health have called for a Tobacco Free Pacific by
2025, a key step in providing the public health leadership
and resources required to drastically reduce tobacco use.
Furthermore, nutrition labels are now mandatory in six
countries, salt targets have already been adopted in five
and twelve countries have introduced a sugar tax [32];
other PICTs are set to follow as capacity expands. The
NCD Country Capacity Survey is a first step in tracking
the uptake of these policies. In taking trade regulation ser-
iously, the PICTs are in a position to potentially set an ex-
ample for many other LMICs. Monitoring and
disseminating information on the implementation and
eventually the impact of these key public health actions
will further support national NCD control efforts.
Global progress
Though most countries have adopted the voluntary tar-
gets of the GMF for NCDs, there is still only limited
progress in implementing the priority interventions, ex-
cept on tobacco control. Countries should consider their
own NCD priorities and capacities before adapting glo-
bal monitoring strategies to their own context. We have
focused on the PICTs since they have begun this process,
but they are not alone. India, for instance, recently un-
veiled a National Multi-sectoral Action Plan in which the
GMF has been adapted and put into action; recognising
the burden due to indoor air pollution, India has added a
tenth target to those proposed by the GMF [33]. The
Caribbean Islands have also recently conducted a data gap
analysis and considered their priorities in terms of inter-
ventions and policy actions [34]. Finally, the US-affiliated
Pacific Islands have developed a detailed monitoring plan
based upon existing data sources [35].
Summary
Better data is the first step in the development and strength-
ening of mechanisms to identify and track public health
challenges within countries and globally, and to be able to
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hold governments and industries accountable for actions
and inactions. Problems with data from the Pacific region
are reflected in the uncertainty in Global Burden of Disease
estimated for the Oceania region, but nascent efforts to
strengthen health information systems in PICTs are evident
and laudable. Nonetheless, efforts need to be intensified
through more effective leadership, technical assistance, and
resources. Though progress in NCD control has been slow,
we have outlined here the valuable lessons that the Pacific
experience thus far can offer other LMICs who are, or soon
will be, struggling to address high NCD burdens, and who
too must deal with scarce resources and a limited health in-
formation system capacity. Prioritising NCD interventions
to suit local needs is critical, and should be accompanied by
careful consideration of the most appropriate and feasible
monitoring strategies to track and evaluate progress.
Despite encouraging signs emerging from the global
development community, led by the WHO, there is wide-
spread and alarming ignorance of the likely scale of the
NCD crisis worldwide, including the Pacific. Regrettably,
NCDs still fail to garner the same international attention
as Maternal and Child Health, perhaps because many
countries, like many of the PICTs, are overcome by the
challenge. Over the last few decades, child mortality has
fallen substantially in the Pacific, yet the continuing rise in
NCDs is largely ignored, despite vociferous calls to action
[36]. Indeed, global health priorities are not an ‘either/or’
proposition; both the massive premature mortality due to
NCDs and the residual Maternal and Child Health agenda
should be at the forefront of global health action in our
quest for a healthier world. The post-2015 agenda pro-
vides us the opportunity to renew our commitment to this
vision while also giving us the unique opportunity to bring
together multiple sectors to address difficult health
problems, like NCDs, effectively and sustainably. Strong
leadership, concerted efforts to strengthen technical
capacity and improved country-level organisation and
resources are essential if we are to make demonstrable
progress in the monitoring and control of key health
challenges, in PICTs, and elsewhere.
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